ATRC

SEC source: 0001323885-23-000031 · wf-form4_167788176034477.xml · nonDerivative · entry 2

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,630

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-23-000031 · wf-form4_167788176034477.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,526

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

SEC source: 0001323885-23-000027 · wf-form4_167788151533845.xml · nonDerivative · entry 2

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,792

F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-23-000027 · wf-form4_167788151533845.xml · nonDerivative · entry 1

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,324

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-23-000028 · wf-form4_167788158601727.xml · nonDerivative · entry 3

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,471

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-23-000028 · wf-form4_167788158601727.xml · nonDerivative · entry 2

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,554

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-23-000028 · wf-form4_167788158601727.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,450

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

SEC source: 0001323885-23-000032 · wf-form4_167788179349757.xml · nonDerivative · entry 5

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 597,053

F4 · price: No consideration was received in connection with this gift to the reporting person's children.

SEC source: 0001323885-23-000032 · wf-form4_167788179349757.xml · nonDerivative · entry 4

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 597,853

F4 · price: No consideration was received in connection with this gift to the reporting person's children.

SEC source: 0001323885-23-000032 · wf-form4_167788179349757.xml · nonDerivative · entry 3

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 598,653

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-23-000032 · wf-form4_167788179349757.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 644,123

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-23-000032 · wf-form4_167788179349757.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 598,130

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

SEC source: 0001323885-23-000033 · wf-form4_167788181929046.xml · nonDerivative · entry 3

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,660

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-23-000033 · wf-form4_167788181929046.xml · nonDerivative · entry 2

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,974

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-23-000033 · wf-form4_167788181929046.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,870

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

SEC source: 0001323885-23-000030 · wf-form4_167788171562478.xml · nonDerivative · entry 3

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,455

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-23-000030 · wf-form4_167788171562478.xml · nonDerivative · entry 2

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,142

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-23-000030 · wf-form4_167788171562478.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,088

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

SEC source: 0001323885-23-000029 · wf-form4_167788165753277.xml · nonDerivative · entry 1

Yount Deborah Lee · CIK 0001926195 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,433

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-23-000017 · wf-form4_167770754682631.xml · derivative · entry 2

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Non-qualified Stock Option (right to buy) · 20,000 shares

Expires 2023-03-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

SEC source: 0001323885-23-000017 · wf-form4_167770754682631.xml · nonDerivative · entry 1

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001323885-23-000004 · wf-form4_167278391044535.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,414

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2022.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022, which is the first trading day of the applicable offering period. The closing price on July 1, 2022 was $41.01.

SEC source: 0001323885-23-000006 · wf-form4_167278411246585.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,635

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2022.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022, which is the first trading day of the applicable offering period. The closing price on July 1, 2022 was $41.01.

SEC source: 0001323885-23-000002 · wf-form4_167278378610543.xml · nonDerivative · entry 1

Yount Deborah Lee · CIK 0001926195 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,194

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2022.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022, which is the first trading day of the applicable offering period. The closing price on July 1, 2022 was $41.01.

SEC source: 0001323885-22-000118 · wf-form4_166906451994225.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 528,896

F1 · price: No consideration was received in connection with this charitable gift.

SEC source: 0001323885-22-000108 · wf-form4_166362055231802.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,406

F1 · price: This transaction was executed in multiple trades at prices ranging from $45.97 to $45.99 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001323885-22-000106 · wf-form4_166214901703770.xml · derivative · entry 2

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Non-qualified Stock Option (right to buy) · 15,000 shares

Expires 2023-03-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

SEC source: 0001323885-22-000106 · wf-form4_166214901703770.xml · nonDerivative · entry 1

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001323885-22-000103 · wf-form4_166007650260076.xml · nonDerivative · entry 1

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,846

F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-22-000092 · wf-form4_165705258646144.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,389

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2022.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022, which is the last trading day of the applicable offering period. The closing price on June 30, 2022 was $40.86.

SEC source: 0001323885-22-000093 · wf-form4_165705262736127.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,490

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2022.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022, which is the last trading day of the applicable offering period. The closing price on June 30, 2022 was $40.86.

SEC source: 0001323885-22-000090 · wf-form4_165705251581219.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 534,896

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2022.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022, which is the last trading day of the applicable offering period. The closing price on June 30, 2022 was $40.86.

SEC source: 0001323885-22-000091 · wf-form4_165705255035232.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,834

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2022.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022, which is the last trading day of the applicable offering period. The closing price on June 30, 2022 was $40.86.

SEC source: 0001323885-22-000085 · wf-form4_165425989526676.xml · nonDerivative · entry 1

Yount Deborah Lee · CIK 0001926195 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,900

F1 · acquired: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-22-000073 · wf-form4_165365658158055.xml · nonDerivative · entry 1

Telman Deborah H · CIK 0001860008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,809

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000072 · wf-form4_165365656472244.xml · nonDerivative · entry 1

Collar Mark A · CIK 0001426353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,871

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000079 · wf-form4_165365668922346.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,435

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000077 · wf-form4_165365665518131.xml · nonDerivative · entry 1

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,999

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000078 · wf-form4_165365667224439.xml · nonDerivative · entry 1

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,799

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000076 · wf-form4_165365663319585.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,809

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000075 · wf-form4_165365661622442.xml · nonDerivative · entry 1

GROVES REGINA E · CIK 0001653877 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,792

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000074 · wf-form4_165365659896970.xml · nonDerivative · entry 1

Prange Karen · CIK 0001566083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,667

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-22-000059 · wf-form4_165279124389871.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,621

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $41.87 to $43.39 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001323885-22-000045 · wf-form4_164976439889793.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,824

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

SEC source: 0001323885-22-000037 · wf-form4_164760829673834.xml · derivative · entry 3

Collar Mark A · CIK 0001426353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Non-qualified Stock Option (right to buy) · 10,000 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on May 15, 2012. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

SEC source: 0001323885-22-000037 · wf-form4_164760829673834.xml · nonDerivative · entry 1

Collar Mark A · CIK 0001426353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001323885-22-000034 · wf-form4_164665769414745.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,106

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $66.71 to $68.66 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001323885-22-000031 · wf-form4_164639677802377.xml · nonDerivative · entry 2

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,515

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $69.20 to $71.71 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001323885-22-000035 · wf-form4_164665771106015.xml · derivative · entry 2

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Non-qualified Stock Option (right to buy) · 15,000 shares

Expires 2023-03-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

SEC source: 0001323885-22-000035 · wf-form4_164665771106015.xml · nonDerivative · entry 1

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.